Interestingly, myocardin upregulation largely restored the expression of the genes controlling FA uptake and oxidation, and glucose metabolism, suggesting a critical role for myocardin in causing lipid and glucose metabolism disorder in Atp6v0d1AKO cardiomyopathy. The gene discussed is MYOCD; the disease is glucose metabolism disease.